These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38852023)

  • 1. Statins to prevent anthracycline-related myocardial toxicity: The jury is still out.
    Mandalà M; Bartolini C; Becattini C
    Eur J Intern Med; 2024 Aug; 126():41-42. PubMed ID: 38852023
    [No Abstract]   [Full Text] [Related]  

  • 2. Statins for Attenuating Cardiotoxicity in Patients Receiving Anthracyclines: A Systematic Review and Meta-Analysis.
    Titus A; Cheema HA; Shafiee A; Seighali N; Shahid A; Bhanushali KB; Kumar A; Khan SU; Khadke S; Thavendiranathan P; Hundley WG; Scherrer-Crosbie M; Nohria A; Neilan TG; Dani SS; Nasir K; Ganatra S
    Curr Probl Cardiol; 2023 Oct; 48(10):101885. PubMed ID: 37336312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins for the Primary Prevention of Anthracycline Cardiotoxicity: A Comprehensive Review.
    Bhasin V; Vakilpour A; Scherrer-Crosbie M
    Curr Oncol Rep; 2024 Oct; 26(10):1197-1204. PubMed ID: 39002055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins for Primary Prevention of Anthracycline Chemotherapy-Related Cardiac Dysfunction: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Agarwal S; Guha A; Krishan S; Naqash AR; Addison D; Yang EH; Barac A; Asad ZUA
    Am J Cardiol; 2023 Nov; 206():63-66. PubMed ID: 37683579
    [No Abstract]   [Full Text] [Related]  

  • 5. Statins as preventive therapy for anthracycline cardiotoxicity: a meta-analysis of randomized controlled trials.
    D'Amario D; Laborante R; Bianchini E; Galli M; Ciliberti G; Mennuni M; Patti G
    Int J Cardiol; 2023 Nov; 391():131219. PubMed ID: 37527752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines.
    Thavendiranathan P; Houbois C; Marwick TH; Kei T; Saha S; Runeckles K; Huang F; Shalmon T; Thorpe KE; Pezo RC; Prica A; Maze D; Abdel-Qadir H; Connelly KA; Chan J; Billia F; Power C; Hanneman K; Wintersperger BJ; Brezden-Masley C; Amir E
    Eur Heart J Cardiovasc Pharmacother; 2023 Sep; 9(6):515-525. PubMed ID: 37120736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardio-protective effects of statins in patients undergoing anthracycline-based chemotherapy: An updated meta-analysis of randomized controlled trials.
    Felix N; Nogueira PC; Silva IM; Costa TA; Campello CA; Stecca C; Lopes RD
    Eur J Intern Med; 2024 Aug; 126():43-48. PubMed ID: 38643042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthracycline-induced cardiotoxicity - are we about to clear this hurdle?
    Dempke WCM; Zielinski R; Winkler C; Silberman S; Reuther S; Priebe W
    Eur J Cancer; 2023 May; 185():94-104. PubMed ID: 36966697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin Exposure and Risk of Heart Failure After Anthracycline- or Trastuzumab-Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study.
    Abdel-Qadir H; Bobrowski D; Zhou L; Austin PC; Calvillo-Argüelles O; Amir E; Lee DS; Thavendiranathan P
    J Am Heart Assoc; 2021 Jan; 10(2):e018393. PubMed ID: 33401953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin Therapy for Prevention of Anthracycline Cardiotoxicity - Another Defeat for Cardioprotection?
    Divakaran S; Nohria A
    NEJM Evid; 2022 Sep; 1(9):EVIDe2200166. PubMed ID: 38319795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular mechanisms of the cardiotoxic action of anthracycline antibiotics and statin-induced cytoprotective reactions of cardiomyocytes].
    Tursunova NV; Klinnikova MG; Babenko OA; Lushnikova EL
    Biomed Khim; 2020 Sep; 66(5):357-371. PubMed ID: 33140729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing anthracycline-induced cardiotoxicity: beginning with the end in mind.
    Salvatorelli E; Menna P; Minotti G
    Future Cardiol; 2015 Jul; 11(4):363-6. PubMed ID: 26239550
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic carbonyl reduction of anthracyclines - role in cardiotoxicity and cancer resistance. Reducing enzymes as putative targets for novel cardioprotective and chemosensitizing agents.
    Piska K; Koczurkiewicz P; Bucki A; Wójcik-Pszczoła K; Kołaczkowski M; Pękala E
    Invest New Drugs; 2017 Jun; 35(3):375-385. PubMed ID: 28283780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis.
    Obasi M; Abovich A; Vo JB; Gao Y; Papatheodorou SI; Nohria A; Asnani A; Partridge AH
    Cancer Causes Control; 2021 Dec; 32(12):1395-1405. PubMed ID: 34406595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk-benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labeling.
    Reichardt P; Tabone MD; Mora J; Morland B; Jones RL
    Future Oncol; 2018 Oct; 14(25):2663-2676. PubMed ID: 29747541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis Evaluating the Use of Statins to attenuate Cardiotoxicity in Cancer Patients receiving Anthracyclines and Trastuzumab-based Chemotherapy.
    Shahid I; Yamani N; Ali A; Kumar P; Figueredo V; Unzek S; Mookadam F
    Am J Cardiol; 2021 Oct; 156():142-145. PubMed ID: 34362551
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity: A Three Dimentional Echocardiography Study.
    Mohamed AL; El-Abd AA; Mohamed HG; Noufal AM; Hennawy BS
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt C):102130. PubMed ID: 37858847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiooncology: Current Aspects of Prevention of Anthracycline Toxicity].
    Vasyuk YA; Shkolnik EL; Nesterov VV; Shkolnik LD; Varlan GV
    Kardiologiia; 2016 Dec; 56(12):72-79. PubMed ID: 28290807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin therapy and anthracycline-related cardiac dysfunction: a meta-analysis of randomized clinical trials.
    Masson W; Barbagelata L; Lobo M; Del Castillo S
    Acta Oncol; 2023 Aug; 62(8):944-947. PubMed ID: 37493519
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity.
    Chung WB; Youn HJ
    Korean J Intern Med; 2016 Jul; 31(4):625-33. PubMed ID: 27378126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.